The ETH Zurich spin-off is advancing three programs based on its proprietary drug delivery platforms. Its iron deficiency anemia candidate is approaching human validation, while a second program ...
Scientific breakthroughs at the Max Planck Society (MPG) often occur at an early stage of development when they are not yet immediately applicable. For such findings to lead to innovative products and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results